Company registration number 4163085 (England and Wales)
BEETHAM NURSERIES LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
BEETHAM NURSERIES LIMITED
COMPANY INFORMATION
Directors
Mr S J Abbit
Mrs L A Abbit
Secretary
Mr S J Abbit
Company number
4163085
Registered office
Beetham Nurseries
Pool Darkin Lane
Milnthorpe
LA7 7AP
Auditor
MHA
14 Mannin Way
Lancaster Business Park
Lancaster
LA1 3SW
BEETHAM NURSERIES LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 22
BEETHAM NURSERIES LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2025
- 1 -
The directors present the strategic report for the year ended 31 January 2025.
Review of the business
This year has proved to be quite challenging with an unusually wet spring, followed by a cool and wet summer together with an increase in operational costs with energy prices increased by 61% and wages by 9.5%.
Turnover for the year was £5,657,860, an increase of approximately 2.65% on the previous year of £5,512,016. Overall, gross profit increased to £3,011,653 with a gross profit margin of 53.2%. Profit for the year fell to £214,554.
The business maintains a strong balance sheet heading into the next financial year with net assets amounting to £4,478,862 and a healthy cash position.
The directors are happy with the recent performance of the business and would like to thank the staff for their continued commitment to the company during this period.
Principal risks and uncertainties
Challenges over the supply of products from overseas continues to be an issue due to various external factors. The directors are continuing to build on close relationships with existing suppliers.
Food price, utility cost and wage inflation along with challenges in relation to the recruitment and retention of staff are all risks that the directors are monitoring closely.
The directors continually implement new operating procedures and are investing in renewables to help mitigate these risks in an ever-changing environment and they closely monitor key performance indicators to help review performance in these areas.
Future Developments
The directors remain committed to a policy of continued improvement and development of the garden centre.
The company aims to maintain and improve customer goodwill by providing quality products at reasonable and competitive prices.
The growing nursery continues to go from strength to strength providing a large range of quality herbaceous plants and the events and workshops are ever popular and highly successful.
Future increase in operational costs will be managed by improving efficiency within the business and by analysing monthly management accounts to highlight areas for improvement.
Mr S J Abbit
Director
31 October 2025
BEETHAM NURSERIES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JANUARY 2025
- 2 -
The directors present their annual report and financial statements for the year ended 31 January 2025.
Principal activities
The principal activity of the company continued to be that of a garden centre and a tea room.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £150,000. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr S J Abbit
Mrs L A Abbit
Auditor
The auditor, MHA, previously traded through the legal entity MacIntyre Hudson LLP. In response to regulatory changes, MacIntyre Hudson LLP ceased to hold an audit registration with the engagement transitioning to MHA Audit Services LLP.
MHA will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.
Strategic report
The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of principal risk and uncertainties, and future developments.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Mr S J Abbit
Director
31 October 2025
BEETHAM NURSERIES LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2025
- 3 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
BEETHAM NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BEETHAM NURSERIES LIMITED
- 4 -
Opinion
We have audited the financial statements of Beetham Nurseries Limited (the 'company') for the year ended 31 January 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 January 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
BEETHAM NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BEETHAM NURSERIES LIMITED (CONTINUED)
- 5 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud, is detailed below:
Enquiries with management about any known or suspect instances of non-compliance with laws and regulations and fraud;
Auditing the risk of fraud in revenue by way of cut off testing as well as sales transaction testing to obtain evidence that revenue is complete and recognised in the correct accounting period;
Challenging assumptions and judgements made by management in their significant accounting estimates, in particular in relation to fixed assets and provisions for the impairment of assets which requires an exercise of management judgement;
An evaluation of the risk of management override of controls and subsequent testing, including through testing journal entries and other adjustments for appropriateness; and
An evaluation of the company's internal control environment.
BEETHAM NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BEETHAM NURSERIES LIMITED (CONTINUED)
- 6 -
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Jack Steer BA(Hons) FCA
Senior Statutory Auditor
For and on behalf of MHA, Statutory Auditor
Lancaster, United Kingdom
31 October 2025
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)
BEETHAM NURSERIES LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 JANUARY 2025
- 7 -
2025
2024
Notes
£
£
Turnover
3
5,657,860
5,512,016
Cost of sales
(2,646,207)
(2,582,902)
Gross profit
3,011,653
2,929,114
Administrative expenses
(2,579,756)
(2,348,411)
Other operating income
13,585
Operating profit
4
431,897
594,288
Interest receivable and similar income
7
3
2
Interest payable and similar expenses
8
(120,440)
(113,600)
Profit before taxation
311,460
480,690
Tax on profit
9
(96,906)
(115,299)
Profit for the financial year
214,554
365,391
The profit and loss account has been prepared on the basis that all operations are continuing operations.
BEETHAM NURSERIES LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2025
- 8 -
2025
2024
£
£
Profit for the year
214,554
365,391
Other comprehensive income
-
-
Total comprehensive income for the year
214,554
365,391
BEETHAM NURSERIES LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2025
31 January 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
11
4,183,481
4,316,177
Current assets
Stocks
12
797,181
810,793
Debtors
13
1,459,529
1,471,799
Cash at bank and in hand
462,939
371,388
2,719,649
2,653,980
Creditors: amounts falling due within one year
14
(1,073,155)
(1,008,372)
Net current assets
1,646,494
1,645,608
Total assets less current liabilities
5,829,975
5,961,785
Creditors: amounts falling due after more than one year
15
(1,240,772)
(1,408,153)
Provisions for liabilities
Deferred tax liability
18
110,339
139,322
(110,339)
(139,322)
Net assets
4,478,864
4,414,310
Capital and reserves
Called up share capital
20
2
2
Profit and loss reserves
4,478,862
4,414,308
Total equity
4,478,864
4,414,310
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 31 October 2025 and are signed on its behalf by:
Mr S J Abbit
Director
Company registration number 4163085 (England and Wales)
BEETHAM NURSERIES LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2025
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 February 2023
2
4,204,917
4,204,919
Year ended 31 January 2024:
Profit and total comprehensive income
-
365,391
365,391
Dividends
10
-
(156,000)
(156,000)
Balance at 31 January 2024
2
4,414,308
4,414,310
Year ended 31 January 2025:
Profit and total comprehensive income
-
214,554
214,554
Dividends
10
-
(150,000)
(150,000)
Balance at 31 January 2025
2
4,478,862
4,478,864
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
- 11 -
1
Accounting policies
Company information
Beetham Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is Beetham Nurseries, Pool Darkin Lane, Milnthorpe, LA7 7AP.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
The financial statements of the company are consolidated in the financial statements of Beetham Nurseries Holdings Limited. These consolidated financial statements are available from its registered office, Beetham Nurseries, Pool Darkin Lane, Beetham, Milnthorpe, LA7 7AP.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 12 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
2% Straight line
Computer Equipment
33.33% Straight line
Fixtures and fittings
25% Straight line
Motor vehicles
25% Reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Stock value consists of the direct cost of materials.
Cost is calculated using the weighted average method.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 13 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 14 -
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 15 -
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense. The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Stock Valuation
The company's stock policy requires judgement to be made in assessing stock for impairment.
At each reporting date, an assessment is made for impairment and any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in the profit or loss.
Property Valuation
The company's accounting policy requirements judgement to be made to determine whether any impairment is present in the valuation of property.
At each reporting date the carrying amount of property is reviewed to determine whether there is any indication that those assets have suffered an impairment loss.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 16 -
3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Nursery and other
4,467,067
4,385,583
Tearooms
1,190,793
1,126,433
5,657,860
5,512,016
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
5,657,860
5,512,016
2025
2024
£
£
Other revenue
Interest income
3
2
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
12,450
11,350
Depreciation of owned tangible fixed assets
195,257
205,222
Depreciation of tangible fixed assets held under finance leases
30,256
20,399
Profit on disposal of tangible fixed assets
(3,258)
-
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Staff
81
79
Directors
2
2
Total
83
81
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
5
Employees
(Continued)
- 17 -
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
1,575,639
1,440,700
Pension costs
48,049
47,702
1,623,688
1,488,402
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
22,700
25,371
Company pension contributions to defined contribution schemes
20,932
24,000
43,632
49,371
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2024 - 2).
7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
3
2
8
Interest payable and similar expenses
2025
2024
£
£
Interest on bank overdrafts and loans
108,709
104,399
Other interest on financial liabilities
2,000
Interest on finance leases and hire purchase contracts
11,731
7,201
120,440
113,600
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
125,889
83,168
Adjustments in respect of prior periods
(21)
Total current tax
125,889
83,147
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
9
Taxation
2025
2024
£
£
(Continued)
- 18 -
Deferred tax
Origination and reversal of timing differences
(28,347)
32,152
Adjustment in respect of prior periods
(636)
Total deferred tax
(28,983)
32,152
Total tax charge
96,906
115,299
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
311,460
480,690
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 24.03%)
77,865
115,511
Tax effect of expenses that are not deductible in determining taxable profit
91
7,652
Group relief
(4,624)
(31,189)
Depreciation on assets not qualifying for tax allowances
23,783
22,804
Other permanent differences
427
Under/(over) provided in prior years
(21)
Deferred tax adjustments in respect of prior years
(636)
Super deduction allowance
(704)
Effect of change in corporation tax rate
1,246
Taxation charge for the year
96,906
115,299
10
Dividends
2025
2024
£
£
Interim paid
150,000
156,000
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 19 -
11
Tangible fixed assets
Freehold land and buildings
Computer Equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 February 2024
5,201,821
110,598
979,208
430,303
6,721,930
Additions
48,774
3,818
42,467
95,059
Disposals
(18,612)
(18,612)
At 31 January 2025
5,250,595
114,416
1,021,675
411,691
6,798,377
Depreciation and impairment
At 1 February 2024
1,198,398
90,553
872,927
243,875
2,405,753
Depreciation charged in the year
104,593
12,048
62,325
46,547
225,513
Eliminated in respect of disposals
(16,370)
(16,370)
At 31 January 2025
1,302,991
102,601
935,252
274,052
2,614,896
Carrying amount
At 31 January 2025
3,947,604
11,815
86,423
137,639
4,183,481
At 31 January 2024
4,003,423
20,045
106,281
186,428
4,316,177
The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.
2025
2024
£
£
Fixtures and fittings
15,128
14,573
Motor vehicles
69,836
156,453
Freehold land and buildings
103,312
105,424
188,276
276,450
12
Stocks
2025
2024
£
£
Finished goods and goods for resale
797,181
810,793
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 20 -
13
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,651
1,017
Amounts owed by group undertakings
1,439,028
1,462,298
Other debtors
4,671
3,609
Prepayments and accrued income
14,179
4,875
1,459,529
1,471,799
14
Creditors: amounts falling due within one year
2025
2024
Notes
£
£
Bank loans
16
105,693
109,390
Obligations under finance leases
17
62,702
76,549
Trade creditors
359,583
436,846
Corporation tax
125,889
83,168
Other taxation and social security
121,275
88,838
Other creditors
261,845
187,551
Accruals and deferred income
36,168
26,030
1,073,155
1,008,372
15
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
16
1,149,519
1,249,294
Obligations under finance leases
17
91,253
158,859
1,240,772
1,408,153
16
Loans and overdrafts
2025
2024
£
£
Bank loans
1,255,212
1,358,684
Payable within one year
105,693
109,390
Payable after one year
1,149,519
1,249,294
Bank loans and overdrafts are secured by way of National Westminster Bank Plc holding a legal charge and debenture over the undertaking and all property and assets present and future, including: goodwill, bookdebts, uncalled capital, buildings fixtures and fixed plant and machinery.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 21 -
17
Finance lease obligations
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
62,702
76,549
In two to five years
91,253
158,859
153,955
235,408
Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 3 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
18
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
110,339
139,322
2025
Movements in the year:
£
Liability at 1 February 2024
139,322
Credit to profit or loss
(28,983)
Liability at 31 January 2025
110,339
The directors do not expect the net reversal of the deferred tax liability in the year beginning after the reporting period to be materially different from the movement shown in the current year.
19
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
48,049
47,702
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
BEETHAM NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 22 -
20
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
2
2
2
2
21
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
Remuneration
2025
2024
£
£
Other related parties
127,052
133,987
2025
2024
Amounts due to related parties
£
£
Key management personnel
137,892
67,714
22
Ultimate controlling party
The directors consider the ultimate parent undertaking to be Beetham Nurseries Holdings Limited, a company incorporated in England and Wales. The largest and only group of which the company is a member and for which group accounts are drawn up is that headed by Beetham Nurseries Holdings Limited.
Copies of group accounts of Beetham Nurseries Holdings Limited, have been delivered to, and are available from, The Registrar of Companies, Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ.
The company is under the ultimate control of the Directors of Beetham Nurseries Holdings Limited, who control, together with members of their close families, the whole of the company’s issued ordinary share capital.
2025-01-312024-02-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200Mrs L A AbbitMrs L A AbbitMr S J Abbit41630852024-02-012025-01-314163085bus:CompanySecretaryDirector12024-02-012025-01-314163085bus:Director12024-02-012025-01-314163085bus:CompanySecretary12024-02-012025-01-314163085bus:Director22024-02-012025-01-314163085bus:RegisteredOffice2024-02-012025-01-3141630852025-01-3141630852023-02-012024-01-314163085core:RetainedEarningsAccumulatedLosses2023-02-012024-01-314163085core:RetainedEarningsAccumulatedLosses2024-02-012025-01-3141630852024-01-314163085core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-314163085core:PlantMachinery2025-01-314163085core:FurnitureFittings2025-01-314163085core:MotorVehicles2025-01-314163085core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-314163085core:PlantMachinery2024-01-314163085core:FurnitureFittings2024-01-314163085core:MotorVehicles2024-01-314163085core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-314163085core:CurrentFinancialInstrumentscore:WithinOneYear2024-01-314163085core:Non-currentFinancialInstrumentscore:AfterOneYear2025-01-314163085core:Non-currentFinancialInstrumentscore:AfterOneYear2024-01-314163085core:CurrentFinancialInstruments2025-01-314163085core:CurrentFinancialInstruments2024-01-314163085core:Non-currentFinancialInstruments2025-01-314163085core:Non-currentFinancialInstruments2024-01-314163085core:ShareCapital2025-01-314163085core:ShareCapital2024-01-314163085core:RetainedEarningsAccumulatedLosses2025-01-314163085core:RetainedEarningsAccumulatedLosses2024-01-314163085core:ShareCapital2023-01-314163085core:RetainedEarningsAccumulatedLosses2023-01-314163085core:ShareCapitalOrdinaryShareClass12025-01-314163085core:ShareCapitalOrdinaryShareClass12024-01-314163085core:LandBuildingscore:OwnedOrFreeholdAssets2024-02-012025-01-314163085core:PlantMachinery2024-02-012025-01-314163085core:FurnitureFittings2024-02-012025-01-314163085core:MotorVehicles2024-02-012025-01-314163085core:UKTax2024-02-012025-01-314163085core:UKTax2023-02-012024-01-31416308512024-02-012025-01-31416308512023-02-012024-01-31416308522024-02-012025-01-31416308522023-02-012024-01-31416308532024-02-012025-01-31416308532023-02-012024-01-31416308542024-02-012025-01-31416308542023-02-012024-01-31416308552024-02-012025-01-31416308552023-02-012024-01-314163085core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-314163085core:PlantMachinery2024-01-314163085core:FurnitureFittings2024-01-314163085core:MotorVehicles2024-01-3141630852024-01-314163085core:WithinOneYear2025-01-314163085core:WithinOneYear2024-01-314163085core:BetweenTwoFiveYears2025-01-314163085core:BetweenTwoFiveYears2024-01-314163085bus:OrdinaryShareClass12024-02-012025-01-314163085bus:OrdinaryShareClass12025-01-314163085bus:OrdinaryShareClass12024-01-314163085bus:PrivateLimitedCompanyLtd2024-02-012025-01-314163085bus:FRS1022024-02-012025-01-314163085bus:Audited2024-02-012025-01-314163085bus:FullAccounts2024-02-012025-01-31xbrli:purexbrli:sharesiso4217:GBP